|
TAS-120 Clinical Trials
2 actively recruiting trials across 1 location
Also known as: Futibatinib
Pipeline
Phase 1: 1Phase 2: 1
Top Sponsors
- Taiho Pharmaceutical Co., Ltd.1
- Taiho Oncology, Inc.1
Indications
- Cancer2
- FGFR2 Fusions1
- Gene Rearrangement1
- Advanced Cholangiocarcinoma1
- Alveolar Soft Part Sarcoma1
Other1 trial
Phase 1
La Jolla, California1 trial
Study of Futibatinib in Patients With Advanced Cholangiocarcinoma With FGFR2 Fusion or Rearrangement
University of California San Diego UCSD - Moores Cancer Center
Phase 2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.